| Immunologic response to cryoablation of breast cancer MS Sabel, MA Nehs, G Su, KP Lowler, JLM Ferrara, AE Chang Breast cancer research and treatment 90, 97-104, 2005 | 229 | 2005 |
| B-RafV600E and thrombospondin-1 promote thyroid cancer progression C Nucera, A Porrello, ZA Antonello, M Mekel, MA Nehs, TJ Giordano, ... Proceedings of the National Academy of Sciences 107 (23), 10649-10654, 2010 | 202 | 2010 |
| A multi-institutional international study of risk factors for hematoma after thyroidectomy MJ Campbell, KL McCoy, WT Shen, SE Carty, CC Lubitz, J Moalem, ... Surgery 154 (6), 1283-1291, 2013 | 125 | 2013 |
| Necroptosis is a novel mechanism of radiation-induced cell death in anaplastic thyroid and adrenocortical cancers MA Nehs, CI Lin, DE Kozono, EE Whang, NL Cho, K Zhu, J Moalem, ... Surgery 150 (6), 1032-1039, 2011 | 122 | 2011 |
| Targeting BRAFV600E with PLX4720 Displays Potent Antimigratory and Anti‐invasive Activity in Preclinical Models of Human Thyroid Cancer C Nucera, MA Nehs, SS Nagarkatti, PM Sadow, M Mekel, AH Fischer, ... The oncologist 16 (3), 296-309, 2011 | 113 | 2011 |
| Genomic correlates of response to everolimus in aggressive radioiodine-refractory thyroid cancer: a phase II study GJ Hanna, NL Busaidy, NG Chau, LJ Wirth, JA Barletta, A Calles, ... Clinical Cancer Research 24 (7), 1546-1553, 2018 | 109 | 2018 |
| Bethesda categorization of thyroid nodule cytology and prediction of thyroid cancer type and prognosis X Liu, M Medici, N Kwong, TE Angell, E Marqusee, MI Kim, PR Larsen, ... Thyroid 26 (2), 256-261, 2016 | 100 | 2016 |
| A novel orthotopic mouse model of human anaplastic thyroid carcinoma C Nucera, MA Nehs, M Mekel, X Zhang, R Hodin, J Lawler, V Nose, ... Thyroid 19 (10), 1077-1084, 2009 | 87 | 2009 |
| Late Intervention with anti-BRAFV600E Therapy Induces Tumor Regression in an Orthotopic Mouse Model of Human Anaplastic Thyroid Cancer MA Nehs, C Nucera, SS Nagarkatti, PM Sadow, D Morales-Garcia, ... Endocrinology 153 (2), 985-994, 2012 | 70 | 2012 |
| Interpretation of intraoperative parathyroid hormone monitoring in patients with baseline parathyroid hormone levels of< 100 pg/mL BS Miller, BG England, M Nehs, RE Burney, GM Doherty, PG Gauger Surgery 140 (6), 883-890, 2006 | 65 | 2006 |
| Treatment of adrenocortical carcinoma A Vaidya, M Nehs, K Kilbridge Surgical Pathology Clinics 12 (4), 997-1006, 2019 | 57 | 2019 |
| Papillary thyroid carcinoma with high-grade features versus poorly differentiated thyroid carcinoma: an analysis of clinicopathologic and molecular features and outcome KS Wong, F Dong, M Telatar, JH Lorch, EK Alexander, E Marqusee, ... Thyroid 31 (6), 933-940, 2021 | 56 | 2021 |
| A cohort analysis of clinical and ultrasound variables predicting cancer risk in 20,001 consecutive thyroid nodules TE Angell, R Maurer, Z Wang, MI Kim, CA Alexander, JA Barletta, ... The Journal of Clinical Endocrinology & Metabolism 104 (11), 5665-5672, 2019 | 56 | 2019 |
| Differential growth rates of benign vs. malignant thyroid nodules TE Angell, CM Vyas, M Medici, Z Wang, JA Barletta, CB Benson, ... The Journal of Clinical Endocrinology & Metabolism 102 (12), 4642-4647, 2017 | 54 | 2017 |
| Quantitative analysis of the benefits and risk of thyroid nodule evaluation in patients≥ 70 years old Z Wang, CM Vyas, O Van Benschoten, MA Nehs, FD Moore Jr, ... Thyroid 28 (4), 465-471, 2018 | 51 | 2018 |
| A phase II study of nivolumab (N) plus ipilimumab (I) in radioidine refractory differentiated thyroid cancer (RAIR DTC) with exploratory cohorts in anaplastic (ATC) and … JH Lorch, JA Barletta, M Nehs, R Uppaluri, EK Alexander, RI Haddad, ... Journal of Clinical Oncology 38 (15_suppl), 6513-6513, 2020 | 50 | 2020 |
| 4D-CT is superior to ultrasound and sestamibi for localizing recurrent parathyroid disease M Hamidi, M Sullivan, G Hunter, L Hamberg, NL Cho, AA Gawande, ... Annals of surgical oncology 25, 1403-1409, 2018 | 47 | 2018 |
| Minimally invasive adrenal surgery: an update MA Nehs, DT Ruan Current Opinion in Endocrinology, Diabetes and Obesity 18 (3), 193-197, 2011 | 42 | 2011 |
| Oncogenic Mutations in PI3K/AKT/mTOR Pathway Effectors Associate with Worse Prognosis in BRAFV600E-Driven Papillary Thyroid Cancer Patients T Pappa, S Ahmadi, E Marqusee, HL Johnson, MA Nehs, NL Cho, ... Clinical Cancer Research 27 (15), 4256-4264, 2021 | 37 | 2021 |
| Tall cell variant of papillary thyroid carcinoma: impact of change in WHO definition and molecular analysis KS Wong, SE Higgins, E Marqusee, MA Nehs, T Angell, JA Barletta Endocrine Pathology 30, 43-48, 2019 | 36 | 2019 |
